IL6 and depressive symptom measurement: Depression has been linked to a range of neuroendocrine and inflammatory response alterations (eg, dysregulation of the hypothalamic-pituitary-adrenocortical axis and elevated C-reactive protein, interleukin 1, and interleukin 6 levels) in clinical and community samples33,34 that might be associated with increased risk of mortality.